Current Drug Targets
Title:Meet Our Editorial Board Member
Volume: 22 Issue: 7
Author(s): S. Lee
Affiliation:
Export Options
About this article
Cite this article as:
Lee S. , Meet Our Editorial Board Member, Current Drug Targets 2021; 22 (7) . https://dx.doi.org/10.2174/138945012207210316111310
DOI https://dx.doi.org/10.2174/138945012207210316111310 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Cell Type-Specific Signal Proteins (Pheromones) of Protozoan Ciliates
Current Pharmaceutical Design CORONAVIRUS and COVID-19: A Systematic Review and Perspective
Current Drug Therapy The Role of Inflammatory and Cytokine Biomarkers in the Pathogenesis of Frailty Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Suicide Gene Therapy Against Malignant Gliomas by the Local Delivery of Genetically Engineered Umbilical Cord Mesenchymal Stem Cells as Cellular Vehicles
Current Gene Therapy Diadenosine Polyphosphates: Postulated Mechanisms Mediating the Cardiac Effects
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Inhalation Delivery of Protein Therapeutics
Inflammation & Allergy - Drug Targets (Discontinued) Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives
Current Vascular Pharmacology Novel Integrin-Specific Targets for Anti-Platelet Therapies
Current Pharmaceutical Design The Vpu Protein and its Role in HIV-1 Pathogenesis
Current Genomics CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis ofCeliac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic
Current Medicinal Chemistry Neovascular Age-related Macular Degeneration: Past, Present, and Future
Current Angiogenesis (Discontinued) The Use of Naltrexone in Dermatology. Current Evidence and Future Directions
Current Drug Targets Applications of Animal Models of Infectious Arthritis in Drug Discovery:A focus on Alphaviral Disease
Current Drug Targets Combined Chemotherapy or Biotherapy with Jasmonates: Targeting Energy Metabolism for Cancer Treatment
Current Pharmaceutical Biotechnology Therapy of Chronic Hepatitis C in the Era of Nanotechnology: Drug Delivery Systems and Liver Targeting
Mini-Reviews in Medicinal Chemistry Molluscum Contagiosum - An Overview
Current Pediatric Reviews Pegaptanib Sodium for the Treatment of Proliferative Diabetic Retinopathy and Diabetic Macular Edema
Current Diabetes Reviews Role of FoxP3<sup>+</sup> Treg Cells Mediating Immune Suppression in Leprosy
Current Immunology Reviews (Discontinued) Selective PGHS-2 Inhibitors: A Rational Approach for Treatment of the Inflammation
Medicinal Chemistry Reviews - Online (Discontinued)